Broadcasting News

Park Yu-na of "Love Is Coming" Reveals New Profile… Showcasing Her Diverse Charm

Appearance on KBS2's "Love Is Coming"

Choi Hee-jae
2026-08-05 16:34:07
[Edaily Starin Choi Hee-jae Reporter] Actress Park Yoo-na has unveiled new profile photos, signaling an active return to the spotlight.
Park Yoo-na (Photo courtesy of KeyEast)

On the 5th, her agency, KeyEast, unveiled new profile photos showcasing Park Yoo-na’s more mature and refined features. The released photos capture her diverse charms, ranging from her fresh, innocent image to her sophisticated, urban appeal.
In a shot where she pairs a black cardigan with pants, Park Yoo-na exudes a modern yet alluring vibe. Her deep gaze and composed expression, complemented by her long, straight hair, further highlight her intellectual and sophisticated charm.
Park Yoo-na (Photo: KeyEast)

She switched up the vibe in a white knit outfit. Her relaxed smile and natural pose toward the camera maximize Park Yoo-na’s signature clean and gentle aura, conveying a pleasant energy.
Park Yoo-na is captivating viewers in her role as Han Gyu-young in the KBS2 weekend drama *Love Is Coming*. She adds tension to the story by portraying the “second-born,” who constantly clashes with her older sister Han Gyu-rim (played by Ahn Hee-yeon), who is devoted to the family.
Park Yoo-na made her debut in the 2015 KBS drama *Cheeky Go-Go* and has since appeared in dramas such as *Secret Forest*, *My ID Is Gangnam Beauty*, *SKY Castle*, *Hotel Del Luna*, *Goddess Descending*, *You and Me: Police Academy*, and *Spirit Fingers*.

Economy

Corporation

IT·Science

Economy

[Market In] E-Land World Moves to Issue 40 Billion Won in Corporate Bonds, Defying the BBB-Rating Downturn

E-Land World (BBB0) is set to issue up to 40 billion won in public corporate bonds. With investor sentiment toward BBB-rated corporate bonds currently subdued, all eyes are on whether the company can …
2026-08-07 18:54:04

Corporation

MedPacto, Inc. Adds Medium-Dose Group to Phase 2 Trial of Baekto-Seetip for Osteosarcoma… Files Application to Amend IND

(Photo courtesy of MedPacto, Inc.) MedPacto, Inc.(235980)is adding a medium-dose patient group to the Phase 2 clinical trial of “Vactosertib,” which it is developing as a treatment for osteosarcom…
2026-08-07 18:21:02

IT·Science

Coreline Soft Co., Ltd. Signs Contract for Lung Cancer Screening Project in Germany… A 10-Year “Jackpot”

Medical artificial intelligence (AI) company Coreline Soft Co., Ltd.(384470)announced on the 7th that it has secured a contract for a lung cancer screening project in Lostau, Germany, through Canon Me…
2026-08-07 18:44:02